Diagnostic and Prognostic Relevance of Acute Kidney Injury Biomarkers in the ICU
ICU 急性肾损伤生物标志物的诊断和预后相关性
基本信息
- 批准号:8521266
- 负责人:
- 金额:$ 17.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-08-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAcute Lung InjuryAcute Renal Failure with Renal Papillary NecrosisAdoptionAdultAdult Respiratory Distress SyndromeAmericanAwardBiological MarkersBiometryCardiacCardiopulmonary BypassCaringCessation of lifeClinicalClinical ResearchClinical TrialsComorbidityComplexCouplingCreatinineCritical IllnessDataData CollectionDetectionDevelopmentDiagnosisDiagnosticDialysis procedureDiseaseEarly DiagnosisEarly identificationEnrollmentEpidemiologyFundingFutureGoalsIncidenceInflammationInjuryInternationalInterventionIschemiaK-Series Research Career ProgramsKidneyLearningLength of StayLiquid ChromatographyMentored Patient-Oriented Research Career Development AwardMentorshipMorbidity - disease rateNational Heart, Lung, and Blood InstituteNephrologyOutcomeOutputPathogenesisPatient CarePatientsPhenotypePopulationPredictive ValueProcessProteinsProteomicsRelative (related person)ResearchResearch PersonnelResearch PriorityRiskRoleSeriesSerumShotgunsSocietiesSpecific qualifier valueStandardizationStratificationSymptomsTechniquesTechnologyTestingTimeTranslatingTroponinTubular formationUrineValidationbasecandidate markercase controlcohortdesignexperienceglomerular filtrationhigh riskimprovedindexinginsightinvestigator trainingmortalitynoveloutcome forecastpatient populationpre-clinicalprognosticprogramsprospectiveskillstandem mass spectrometrytranslational study
项目摘要
DESCRIPTION (provided by applicant): The Mentored Patient-Oriented Research Career Development Award (K23) will enable Dr. Edward D. Siew to develop into an independent investigator in the clinical and translational study of acute kidney injury (AKI) and establish an independent research program focused on critical illness-associated kidney injury. Through the availability of a carefully constructed program of didactic activities in clinical proteomics, advanced epidemiology, and biostatistics; intensive mentorship by local and international experts; and direct experience in the design, implementation, and interpretation of data derived from a large prospective cohort of critically ill adults, Dr. Siew will use this award to become a highly trained investigator in AKI research. The primary scientific aims of this proposal are to examine the independent and additive impact of biological markers of injury for the early detection and prognosis of AKI in the critically ill and to apply emerging proteomic technology towards the discovery of novel protein markers able to predict progression of injury at the time of early diagnosis. Despite advances in the provision of care, AKI remains a common and devastating occurrence in the critically ill and an independent predictor of morbidity and mortality. Attempts at translating promising interventions into improved outcomes in AKI have been limited belated and unreliable markers of injury (i.e. changes in serum creatinine and urine output) that provide little information on the timing and mechanisms of ongoing injury. These limitations are further magnified in a mixed ICU patient population where the timing and extent of injury is more difficult to define. Using a large, well- phenotyped prospective cohort of critically ill adults (The Validation of Biomarkers for Acute Lung Injury Diagnosis/VALID Study), this proposal will test the hypothesis that a biomarker panel consisting of specific indicators of kidney injury will have independent and additive value for the early diagnosis and prognosis of AKI in a mixed adult ICU population (Specific Aims 1a and 1b). The candidate will learn to apply emerging proteomic techniques such as liquid- chromatography tandem mass-spectrometry (LC-MS-MS) towards discovering and verifying new potential protein targets able to predict progression of injury at the time of initial AKI diagnosis (Specific Aim 2). The proposed research plan will further define the role of promising candidate markers in providing additional pathophysiologic insight, enhancing risk stratification, and facilitating clinical trial enrollment. Further, the research included in this proposal will also provide this candidate with the skill set and experience to develop into a successful independent investigator able to make significant contributions toward improving the care of patients with this disease.
描述(由申请人提供):指导患者为导向的研究职业发展奖(K23)将使博士爱德华D。Siew将发展成为急性肾损伤(阿基)临床和转化研究的独立研究者,并建立一个专注于危重病相关肾损伤的独立研究项目。通过在临床蛋白质组学,先进流行病学和生物统计学方面精心构建的教学活动计划的可用性;当地和国际专家的密集指导;以及在设计,实施和解释来自大型危重病成人前瞻性队列的数据方面的直接经验,萧博士将利用这个奖项成为阿基研究中训练有素的研究员。该提案的主要科学目的是检查损伤生物标志物对危重患者阿基早期检测和预后的独立和附加影响,并将新兴蛋白质组学技术应用于发现能够在早期诊断时预测损伤进展的新型蛋白质标志物。尽管在提供护理方面取得了进展,但阿基仍然是危重患者中常见的毁灭性事件,也是发病率和死亡率的独立预测因素。将有希望的干预措施转化为改善阿基结局的尝试有限,迟来的和不可靠的损伤标志物(即血清肌酐和尿量的变化)提供的关于持续损伤的时间和机制的信息很少。这些局限性在混合ICU患者人群中进一步放大,其中损伤的时间和程度更难以定义。使用一个大型的、表型良好的危重成人前瞻性队列(急性肺损伤诊断生物标志物验证/VALID研究),该提案将检验以下假设:由肾损伤特定指标组成的生物标志物组对混合成人ICU人群中阿基的早期诊断和预后具有独立和附加价值(特定目的1a和1b)。候选人将学习应用新兴的蛋白质组学技术,如液相色谱串联质谱(LC-MS-MS),以发现和验证能够在初始阿基诊断时预测损伤进展的新的潜在蛋白质靶点(具体目标2)。拟议的研究计划将进一步确定有前途的候选标志物在提供额外的病理生理学见解,增强风险分层和促进临床试验招募方面的作用。此外,本提案中包含的研究还将为该候选人提供技能和经验,使其成为一名成功的独立研究者,能够为改善该疾病患者的护理做出重大贡献。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Recent advances in acute kidney injury epidemiology.
- DOI:10.1097/mnh.0b013e3283521d95
- 发表时间:2012-05
- 期刊:
- 影响因子:3.2
- 作者:Siew ED;Deger SM
- 通讯作者:Deger SM
The growth of acute kidney injury: a rising tide or just closer attention to detail?
- DOI:10.1038/ki.2014.293
- 发表时间:2015-01
- 期刊:
- 影响因子:19.6
- 作者:
- 通讯作者:
Acute kidney injury: a not-so-silent disease.
- DOI:10.1038/ki.2013.389
- 发表时间:2014-03
- 期刊:
- 影响因子:19.6
- 作者:Siew, Edward D.;Furth, Susan L.
- 通讯作者:Furth, Susan L.
Urinary Biomarkers are Associated with Severity and Mechanism of Injury.
- DOI:10.1097/shk.0000000000000784
- 发表时间:2017-05
- 期刊:
- 影响因子:0
- 作者:Janak JC;Stewart IJ;Sosnov JA;Howard JT;Siew ED;Chan MM;Wickersham N;Ikizler TA;Chung KK
- 通讯作者:Chung KK
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Edward D Siew其他文献
Edward D Siew的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Edward D Siew', 18)}}的其他基金
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
提高退伍军人急性肾损伤后护理的安全性和质量
- 批准号:
10176246 - 财政年份:2015
- 资助金额:
$ 17.28万 - 项目类别:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
提高退伍军人急性肾损伤后护理的安全性和质量
- 批准号:
8866652 - 财政年份:2015
- 资助金额:
$ 17.28万 - 项目类别:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
提高退伍军人急性肾损伤后护理的安全性和质量
- 批准号:
10176181 - 财政年份:2015
- 资助金额:
$ 17.28万 - 项目类别:
Improving Safety and Quality of Care Among Veterans Following Acute Kidney Injury
提高退伍军人急性肾损伤后护理的安全性和质量
- 批准号:
9145498 - 财政年份:2015
- 资助金额:
$ 17.28万 - 项目类别:
Diagnostic and Prognostic Relevance of Acute Kidney Injury Biomarkers in the ICU
ICU 急性肾损伤生物标志物的诊断和预后相关性
- 批准号:
8190130 - 财政年份:2011
- 资助金额:
$ 17.28万 - 项目类别:
Diagnostic and Prognostic Relevance of Acute Kidney Injury Biomarkers in the ICU
ICU 急性肾损伤生物标志物的诊断和预后相关性
- 批准号:
8303228 - 财政年份:2011
- 资助金额:
$ 17.28万 - 项目类别:
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 17.28万 - 项目类别:














{{item.name}}会员




